Kevin Tang's Concentra snags another buyout, this time for IGM Biosciences
Kevin Tang is on a hot streak.
Concentra Biosciences, the shell company from his hedge fund Tang Capital, has secured its fourth buyout of a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
